FUNDING
WHO
STATUS
Concluded
LOCATION
Kampala, Uganda
KIND OF INTERVENTION
Development
Project’s beneficiaries
Kampala district and Northern Uganda people suffering of Tuberculosis.
Problems to solve
Crucial is the early diagnosis of tuberculosis to prevent further diffusion of the infection and to benefit the patients with a proper treatment especially when they are young. Moreover the compliance to a proper treatment protocol is the best way to prevent the Multi Drug Resistant Tuberculosis.
Long distances, costs, scarcity of microscope and lab reagents, poor qualified personnel, make a proper diagnosis of pulmonary tuberculosis a challenge. The project main aim is to improve the rate of correct diagnosis of Tuberculosis, enhancing the capacities of the peripheral TB laboratories.
PROJECT SITES
Kampala – Gulu
AIM
Improve the capacities of diagnosing pulmonary TB in the peripheral laboratories of Kampala and Gulu districts.
SPECIFIC GOALS
– Perform external quality control of the laboratories of Kampala district
– Enhance the capacity of Lacor Hospital Laboratory to become referral centre for Northern Uganda
– Develop the capacities of Nsambya Hospital to perform molecular biology procedures on TB diagnosis
FUNDSING
WHO 420.743,13 EUROS
PROGRAMME’S STATUS
Ended on 30/10/13
LOCAL PARTNERS
St. Francis Nsambya Hospital in Kampala
St. Mary’s Lacor Hospital of Gulu
National TB Laboratory
The collaboration between AISPO and National TB and Leprosy Control Program (NTLP) lasts since 2006. Since then AISPO is an active member of Uganda Stop TB Partnership (USTP). USTP is an entity which was created in 2004 with 27 partners (bilateral and multilateral cooperation agencies), to fight TB and reduce its morbidity in Uganda to the 1990 levels (Millenium Development Goals).
NTLP had already given Nsambya Hospital the responsibility to perform external quality controls within Kampala and Central Zone laboratories.
Nowadays AISPO and Nsambya Hospital do operate under the NTLP and USTP supervising the performance of 130 laboratories.
Quarterly at the site supervision of the procedure regarding collection, reception, stain of the samples, microscopic investigation and report registration.
Professional updating of the lab technicians both with practical and theoretical actions.
Quarterly report to NTLP and proposition of the due action to tackle the weakness of the programme, to maintain and improve overall performance.
Aispo is continuing ita monitoring and quality assurance activity that includes more laboratories.
AISPO, in the framework of this project, has launched a laboratory for TB culture within the St. Mary’s Lacor Hospital in Gulu. Two rooms have been renovated and equipped with biomedical devices. Recently the technician responsible of the TB service has been recruited. It has also been introduced, in partnership with IDI (infectious Disease Institute), a device for biomolecular biology (GenXpert) for the diagnosis on DNA, with a response time of just two hours.
The project ended on 30th October 2013.
This work has allowed the draft of an abstract and a poster that have been discussed at the international TB congress held in Paris from 29 October to 4 November 2013, presenting data from a seven years long work.
